A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
47.49 +0.00 (0.00%) AZN

Click Here to Receive Instant E-mail and RSS Alerts


Trade AZN now with

Stock Details

Last Trade:47.49 Change:+0.00 (0.00%) Prev Close:47.49 Open: 0.00 Days Range:47.49 – 47.49 52 Week Range: 40.89 - 52.54 Volume:3702347 P/E: N/A
EPS:0.00





Recent Blog Posts

Blog Posts on 02/09/12 at 7:13am
5 Pharmaceutical Stocks To Consider Now
Blog Posts on 02/08/12 at 6:22pm
U.K. Mega Caps Earnings And Dividend Update
Blog Posts on 02/08/12 at 2:53am
7 Large-Cap Dividend Stocks Undervalued By Levered Free Cash Flows
Blog Posts on 02/07/12 at 7:23pm
Big Pharma's Potential Consumer Growth Avenue
Blog Posts on 02/07/12 at 3:10pm
Big, Robust Pipelines At Small Biotech Companies
Blog Posts on 02/07/12 at 10:46am
IPO Preview: ChemoCentryx
Blog Posts on 02/07/12 at 4:34am
Performance Results Of The Potency Score System
Blog Posts on 02/06/12 at 6:18pm
Rigel Pharma Has More Room To Run
Blog Posts on 02/06/12 at 4:48pm
Investment Strategy Review: 'Graham And Dodds-Ville'
Blog Posts on 02/06/12 at 3:27pm
Protecting Your Merck Investment
Blog Posts on 02/06/12 at 9:26am
Biotech Stocks To Watch In 2012
Blog Posts on 02/06/12 at 6:31am
Small Pharma With Big Compounds: Final Dance With The FDA
Blog Posts on 02/06/12 at 2:01am
Best Dividend Growth Stocks By Potency Score For February
Blog Posts on 02/05/12 at 12:20pm
AstraZeneca Axes 7,300 Jobs, 12% Of Workforce
Blog Posts on 02/05/12 at 6:49am
AstraZeneca's Shrinking Act Could Increase Its Appeal
Blog Posts on 02/05/12 at 6:28am
The Week In Review: Are WuXi PharmaTech And ShangPharma Takeover Targets?
Blog Posts on 02/03/12 at 4:26pm
AstraZeneca - Solid Earnings Overwhelmed By An Uncertain Future
Blog Posts on 02/03/12 at 2:53pm
Merck Looks Like A Name To Own In Drugs
Blog Posts on 02/03/12 at 5:14am
The Birth Control Pill Fiasco: Will It Be Bad For Pfizer?
Blog Posts on 02/02/12 at 8:40am
An Income-Growth Portfolio For 2012: 4%+ Yield, Dividend Growth And Lower Beta
Blog Posts on 01/30/12 at 3:01pm
Expecting Catalyst Action For Astex Pharmaceuticals
Blog Posts on 01/27/12 at 9:02am
8 High Dividend Stocks With Strong Fundamentals
Blog Posts on 01/24/12 at 5:01pm
7 Plays With Superb Yields As High As 19%
Blog Posts on 01/23/12 at 7:19am
Nektar Therapeutics: Often Forgotten, But Worth A Look
Blog Posts on 01/22/12 at 4:44am
Seattle Genetics: Boxed Warning Is A Non-Event
Blog Posts on 01/20/12 at 10:00am
FDA Rejection Of Dapaglifozin Means Little For Lexicon
Blog Posts on 01/20/12 at 7:59am
Diabetes Drug Hits Dead End
Blog Posts on 01/19/12 at 1:30pm
Astex Pharmaceuticals Faces FDA Decision On March 6
Blog Posts on 01/18/12 at 3:54pm
Investment Opportunities In 10 Big Pharmaceutical Companies
Blog Posts on 01/17/12 at 7:43am
4 Dividend Stocks To Consider And 2 To Avoid